Results 161 to 170 of about 319,380 (216)

Interstitial Lung Disease Induced by Monoclonal Antibodies for Psoriatic Arthritis, a Double Hit: A Case Report with a Literature and Clinical Trial Review. [PDF]

Pulm Ther
Castelli G, Fiorentù G, Maggioni G, Bellani S, Giulianelli G, Bernardinello N, Cocconcelli E, Pezzuto F, Polverosi R, Calabrese F, Spagnolo P, Balestro E.   +11 more
europepmc   +1 more source

Long-Term Effectiveness of Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: A 104-week Real-World Clinical and Ultrasound Study. [PDF]

Psoriasis (Auckl)
Graceffa D, Sperati F, Fargnoli MC, Cameli N, Pacifico A, Demofonte I, Lora V.   +6 more
europepmc   +1 more source

Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage. [PDF]

Clin Pract
Bernardini N, Marotta G, Skroza N, Graceffa D, Bragazzi MC, Finistauri Guacci L, Tolino E, Sasso FP, Gallo U, Richetta AG, Dattola A.   +10 more
europepmc   +1 more source

Association of Early-Life Exposures With Later Diagnosis of Spondyloarthritis: A Population-Based Case-Control Study. [PDF]

J Rheumatol
Altaffer AL, Weisman MH, Kaplan RM, Horváth-Puhó E, Sørensen HT, Weiss PF.   +5 more
europepmc   +1 more source

IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence. [PDF]

Ther Adv Musculoskelet Dis
Paci V, Foti R, Pantano I, Carletto A, Celletti E, Miceli GF, Cangemi I, Lopalco G, Montalbano S, Chimenti MS, Picchianti Diamanti A, Massafra U, Filippucci E, Parisi A, Leccese P, Panaccione A, Puca I, Amato G, Marrone S, Di Penta M, Corrao S, Cela E, Rai A, Tirri E, Iannone F, Atzeni F, Rossini M, Ciccia F, Foti R, Moroncini G, Luchetti Gentiloni MM.   +30 more
europepmc   +1 more source

Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study. [PDF]

Biomedicines
Pinto-Tasende JA, Garcia-Porrua C, Maceiras-Pan F, Melero-González RB, Hernandez Del Rio A, Cervantes Pérez EC, Quevedo-Vila V, Iñiguez CL, Alonso-Castro S, Caeiro-Aguado M, Queiro R.   +10 more
europepmc   +1 more source

Maresin-1 and maresin-2 as synovial fluid biomarkers in psoriatic, rheumatoid, and osteoarthritis. [PDF]

Front Med (Lausanne)
Demir S, Can B, Esmez O, Aydin MA, Gencer SY, Bildirici F, Koca SS, Sahin İ, Aydin S.   +8 more
europepmc   +1 more source

Efficacy and safety evaluation of adalimumab for psoriatic arthritis: A meta-analysis. [PDF]

Medicine (Baltimore)
Cai Z, Yan L, Zhang Y.
europepmc   +1 more source

Improving Lipid Screening Adherence in Inflammatory Arthritis Using a Two-Cycle Plan-Do-Study-Act (PDSA) Quality Improvement Intervention. [PDF]

Cureus
Lilly M, Javed M, Jagannath D, Monga K.
europepmc   +1 more source

Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF: post hoc analysis of SELECT-PsA 2. [PDF]

RMD Open
Coates LC, Mease P, Kavanaugh A, Merola JF, Magrey M, Iyile T, Zhou L, Novelli L, Lagunes I, Setty AR, Van den Bosch F.   +10 more
europepmc   +1 more source